For the past two and a half years, I have been a postdoctoral research fellow, part of the Molecular Oncology group at the Cancer Research UK Manchester Institute, where I have been working to understand how prostate cancer develops so we can give patients the most appropriate clinical care.

Prior to that, I spent two years at the University of Southampton Cancer Sciences Institute studying the causes of a very rare form of blood cancer, Splenic Marginal Zone Lymphoma, and uncovered a new genetic change seen in very many patients. This has helped understand why people develop this cancer, as well as hopefully finding better treatments for it.

I completed my PhD at the University of Sheffield in 2011, where I was investigating the genetic events responsible for inherited susceptibility to breast and prostate cancer. Our aim was to improve breast and prostate cancer screening to target it to the people who would benefit most.